Eupraxia Pharmaceuticals Inc.
TSX:EPRX.TO
3.45 (CAD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 25.504 | 24.736 | 20.892 | 0.15 | 1.156 | 0.823 | 3.99 |
Short Term Investments
| 0 | 0 | 9.009 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 25.504 | 24.736 | 29.901 | 0.15 | 1.156 | 0.823 | 3.99 |
Net Receivables
| 0.251 | 0.122 | 0.43 | 0.621 | 1.348 | 1.484 | 1.312 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 0.357 | 0.32 | 0.271 | 0.368 | 0.134 | 0.167 | 0.121 |
Total Current Assets
| 26.112 | 25.177 | 30.602 | 1.138 | 2.639 | 2.474 | 5.423 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 0.602 | 0.695 | 0.589 | 0.315 | 0.646 | 0.435 | 0.419 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.009 | 0.003 | 0.031 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 0.611 | 0.699 | 0.62 | 0.315 | 0.646 | 0.435 | 0.419 |
Total Assets
| 26.723 | 25.876 | 31.222 | 1.454 | 3.285 | 2.909 | 5.842 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Short Term Debt
| 13.782 | 0.176 | 0.155 | 12.57 | 11.686 | 3.793 | 0.007 |
Tax Payables
| 0.048 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 11.764 | 3.966 | 2.113 | 9.972 | 8.981 | 10.552 | 0.723 |
Total Current Liabilities
| 25.546 | 4.142 | 2.268 | 22.542 | 20.667 | 14.344 | 0.731 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0 | 10.37 | 9.401 | 0.199 | 0.251 | 0 | 0.005 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0.376 | 0.498 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 10.37 | 9.401 | 0.575 | 0.749 | 0 | 0.005 |
Total Liabilities
| 25.546 | 14.512 | 11.669 | 23.117 | 21.416 | 14.344 | 0.736 |
Equity: | |||||||
Preferred Stock
| 0 | 2.786 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 122.516 | 92.337 | 80.713 | 23.798 | 23.548 | 23.548 | 23.586 |
Retained Earnings
| -139.114 | -97.446 | -74.187 | -51.197 | -47.2 | -40.024 | -20.109 |
Accumulated Other Comprehensive Income/Loss
| -3.569 | -2.786 | 16.56 | -0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 23.089 | 17.964 | -2.7 | 6.19 | 5.961 | 5.416 | 2.5 |
Total Shareholders Equity
| 2.922 | 12.855 | 20.387 | -21.21 | -17.69 | -11.059 | 5.978 |
Total Equity
| 1.177 | 11.364 | 19.553 | -21.664 | -18.131 | -11.435 | 5.106 |
Total Liabilities & Shareholders Equity
| 26.723 | 25.876 | 31.222 | 1.454 | 3.285 | 2.909 | 5.842 |